Clinical trial
Tamoxifen in Treating Patients With Primary Liver Cancer
NCT00003424 · National Medical Research Council (NMRC), Singapore, Other · Completed
Key facts
| NCT number | NCT00003424 |
|---|---|
| Title | Tamoxifen in Treating Patients With Primary Liver Cancer |
| Official title | Randomised Trial of Tamoxifen Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma |
| Lead sponsor | National Medical Research Council (NMRC), Singapore, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug |
| Interventions | tamoxifen citrate |
| Enrollment | 300 |
| Start date | Apr 1, 1997 |
| Primary completion | Jun 1, 2000 |
| Completion | Aug 1, 2009 |
| First posted | Aug 4, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | Hong Kong, Indonesia, Malaysia, New Zealand, Pakistan, Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: